WHOLEPOWER BIOTECH UK LTD.

Reliable Testing Excellence and Quality

Wholepower is a global leader in Research & Development, Manufacturing, Marketing and Distribution of Rapid Colloid Gold Assay Tests and Time-Resolved Immunofluorescence Quantitative Diagnostic Reagents and Analysers etc.

 

ABOUT US

Wholepower Biotech UK Ltd. is committed to providing a variety of quality merchandise for customers. By using the latest technologies and applying strict quality control procedures, we’ve become known for having the best products in the industry.

Annotation 2020-06-07 133632.png
 

OUR COVID-19 STRATEGY

Highly Trained, Highly Effective

Countries around the world are facing problems with solely using PCR tests to test for COVID-19 as it is a time-consuming and costly process.

Using only PCR tests is not a sufficient strategy to achieve mass testing in order to safely re-open the economy. The current Center of Disease control (CDC) recommendation to control costs while providing a robust testing plan is to use RDT (antibody tests) to screen and PCR (virus tests) to confirm positive cases. Our RDT tests provides a result with 97.4% accuracy in 15 minutes, giving a good baseline for containing the spread of the disease. We plan to aid in the testing effort by using a combination strategy to efficiently test a large amount of people with a combined strategy and offer continuous follow-up monitoring with RDT kits.


Any rapid test that could be used to identify infected individuals during this pandemic, especially those who are asymptomatic, is very important. Used as a screening test, individuals testing positive could at least be isolated while they are tested by the confirmatory PCR test.

 

OUR CLIENTS





With years of expertise and experience, Wholepower Biotech UK Ltd. is proud to be regarded as a manufacturing leader. Every decision is inspired by our main mission, which is to provide the highest standard of product and services to our customers globally.

 

THE TEAM

raymond-asquith-3rd-earl-of-oxford-and-a

RAYMOND OXFORD OBE, EARL OF OXFORD AND ASQUITH

Non-Executive Chairman

Raymond Oxford OBE, Earl of Oxford and Asquith, attended Farleigh School and Ampleforth College, before graduating with a Master of Arts from Balliol College, Oxford.  He is the great-grandson of the former Liberal Prime Minister H H Asquith. Continuing in the footsteps of a long line of diplomats, he worked in the Diplomatic Service for nearly 20 years after beginning his career in 1980. During his time in the field he has worked in the Foreign and Commonwealth Office, the Cabinet Office and numerous postings in Eastern Europe. He was First Secretary at the British Embassy in Moscow from 1983 to 1985 during the Cold War and went on to be a Counsellor at the Embassy in Kiev in the 1990s. He was elected to the House of Lords in October 2014 following the death of Lib Dem Hereditary Peer Lord Methuen.

MICHELLE SHE

Chief Executive Officer

Michelle graduated with honours from the University of Toronto. She has spent most of her career at Accenture in management consulting in areas including healthcare, financial services and public entities. Michelle has strategised and liaised with the most research intensive childrens’ hospital in Canada to improve their medical research methods and data capacity. She has also planned and executed financial services projects from trading to asset management to financial technology.

headshot_edited_edited.jpg
WeChat Image_20200607175510.jpg

MICHAEL HSU

Head of Strategy

Michael received his MSc from London School of Economics and is an entrepreneur and financier with more than 20 years of experience in cross-border transactions and fund raising across a range of sectors, including renewable energy infrastructure, real-estate, financial markets and environmental technology. Michael works closely with high net worth individuals, family offices and investment funds across the globe. He has founded several successful technology and financial services businesses. In addition, he has consulted on strategic planning, structured financing and corporate development for a diverse array of organisations, ranging from start-ups to Fortune 500 companies.

PHILIP SOUTHWELL BA BPF FCA

Financial Director

Philip graduated from Durham University & Eton College. After training with Touche Ross (now Deloitte) & becoming a Fellow of the Institute of Chartered Accountants in England & Wales, Philip’s investment banking career started in 1994 with Smith New Court (Merrill Lynch) & he then spent 13 years at Deutsche Bank where he was promoted from Head of ECM in the UK to Head of Asia-Pacific for ECM; to Head of Europe for ECM; to Head of Coverage for Corporate & Investment Banking (“CIB”) EMEA; Board Director in Russia; to Head of CIB in Eastern Europe, Middle East & Africa; & COO for CIB in EMEA. Philip has experience globally & has transacted more than $100 billion of advisory and capital markets deals. He was appointed restructuring advisor to Dubai World in 2008, listed Halifax in the UK in 1997, AMP in Australia in 1998, China Life in 2003, DP World in 2007, USAID Tunisia bond in 2012, MTN Nigeria in 2019.

WeChat Image_20200607142204.jpg
WeChat%252520Image_20200608073521_edited_edited_edited.jpg

WILLIAM GAO

Head of Manufacturing

Will has over 18 years’ experience in the IVD industry focusing in Point of Care Tests (POCT). He is especially experienced in trans-country manufacturing support and audit. He holds a masters degree in International Business and Management. Will has been leading the PMC and Customers Service Team, supporting global partners in Asia, Africa, South America, Middle East, European Union etc. through local installation and working with local teams. He has extensive experience in supporting global leading chain pharmacies, clinics, hospitals in the European Union and USA and government tenders in Africa and Asia with his test manufacturing plant.

 

OUR ADVISORS

DR. XIAOJIU ZHU MBE PHD

Dr. Zhu obtained her doctorate in Biochemistry and worked many years as a post doctor scientist with MIT USA in the field of host immunity and vaccine development. She continued her work in London at Imperial Cancer Research Fund (ICRF) and the Medical Research Council (MRC) before studying law at the College of Law London. She completed her articles with Clifford Chance and worked briefly for Rouse & Co International London office, a firm specialising in Intellectual property. Dr Zhu is fluent in Mandarin and currently acts for Chinese corporate and private investors in their investments into the UK which recently included an acquisition of a TV station. Combining her legal knowledge with her scientific analytical skills, she offers practical & dynamic solutions to clients’ legal issues. She is the founder and President of the UK Society of Chinese Lawyers; Honorary President of UK China Economic and Trade Exchange Association

PROF. HYWEL R. THOMAS CBE FRENG FRS

Professor Thomas is Professor of Civil Engineering at Cardiff University, the founder Director of the Geoenvironmental Research Centre (GRC) at the University, and a UNESCO Professor in the Development of a Sustainable Geoenvironment. He is a Distinguished Research Professor at Swansea University. He also leads FLEXIS, a £24 million project for energy systems research in Wales. He is a Fellow of the Royal Society (FRS), a Fellow of the Royal Academy of Engineering (FREng), a Member of Academia Europaea, the Academy of Europe, President of the Learned Society of Wales and Honorary Professor at Zhejiang University, China. He was a Pro-Vice Chancellor of Cardiff University from 2010 to 2018. In 2017 he received a CBE for services to academic research and higher education.

VINCENT LOH

Vincent spearheads CPG’s global operations and has forged strong relationships in ASEAN, Singapore, Middle East, India and Sri Lanka. Vincent has helped CPG, the former public work department of Singapore with over 180 years of history, curate their portfolio in over 25 countries including healthcare facilities, airports, educational & research facilities etc.. With a diverse portfolio of projects, comprising general hospitals, specialist centres, community hospitals, nursing homes and polyclinics, as well as other related biomedical buildings, Vincent has extensive experience and skills in the design of healthcare facilities. He draws on his years of experience in senior management to inspire best practices and leadership.

KEN LUM

Ken received his PhD from the University of Liverpool. He was a research scientist and research manager with Environment Canada. As Secretary of the Commonwealth Science Council, he led and managed the science, technology and innovation program of the Commonwealth. He has worked for IUCN, Wetlands International, and the World Water Council. And has been a consultant to UNIDO, Cardiff School of Engineering, the Ramsar Convention, and the OECD.

 

CONTACT US

29-31 Castle Street
High Wycombe
United Kingdom

 

©2020 by Wholepower Biotech UK Ltd.

Closeup of a Petri Dish